A Randomized Single Blind Safety and Efficacy Study of TOL-463 Vaginal Gel or Insert in the Treatment of Vaginitis (BV and/or VVC)
Phase of Trial: Phase II
Latest Information Update: 13 Mar 2018
At a glance
- Drugs TOL 463 (Primary)
- Indications Bacterial vaginosis; Vulvovaginal candidiasis
- Focus Therapeutic Use
- 20 Jul 2017 Status changed from active, no longer recruiting to completed.
- 18 May 2017 Planned primary completion date changed from 1 Jan 2017 to 10 Jun 2017.
- 18 May 2017 Status changed from recruiting to active, no longer recruiting.